be_ixf;ym_202605 d_05; ct_50

Latest Insights on FL

david and goliath amazon Amazon’s $1 Trillion Playbook: How to Buy the Next Market Disruptor February 6, 2020 by Charles Mizrahi American Investor Today, Trading Strategies Today, Amazon and Netflix are known as industry disruptors. But in their early days, they were considered underdogs going up against giant brick-and-mortar retail chains. Today, Charles Mizrahi uncovers the one secret that underpins “underdogs” such as Netflix and Amazon.
The latest U.S. private payrolls data are in, and the economy is looking stronger than ever! (If you judge things solely on jobs data, that is.) Jobs Wow Wall Street … Disney, Not so Much February 5, 2020 by Joseph Hargett Great Stuff Keepin’ the Bulls Happy I live for moments like today, dear reader. The latest U.S. private payrolls data are in, and the economy is looking stronger than ever! (If you judge things solely on jobs data, that is.) Yes, I know I preach a bit of doom and gloom from time to time, but someone […]
Make 35% by July 4 With Exxon Mobil February 5, 2020 by John Ross American Investor Today, Oil Wall Street is dumping this energy giant over a tough quarter. John Ross shares how to make 26% on Exxon's rally by Independence Day.
If you don’t think the Wuhan coronavirus outbreak will impact the U.S. economy, I’ve got some bad news for you. The Chinese Time Bomb; Tesla Tendies Time February 4, 2020 by Joseph Hargett Great Stuff The Ticking Chinese Time Bomb Sorry to ruin your bull market party, but there’s an issue we need to discuss … like, right now. I’m talking about the Wuhan coronavirus and the U.S.-China “phase 1” trade deal. Here’s the thing: More than 20,000 Chinese are infected with the Wuhan virus, with some 427 dead. Tens […]
abbvie stock Profit From AbbVie’s Struggles Today February 4, 2020 by Chad Shoop American Investor Today, Stocks Abbvie’s flagship medication Humira is a huge seller in the U.S. and abroad. But as more companies develop their own versions, will Abbvie’s stock crater in the face of tighter competition? I’ll review Abbvie’s balance sheet and fundamentals to let you know whether you should expect the stock to surge — or fall even further in 2020.

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

“Loving the 238% gain after I bought your recommendation in Sept. 2019! This week (July 21, 2020) will be my 1 year anniversary with your amazing team … thanks for the life-changing work you all do! Between all your services, 14 triple-digit gains, the greatest at 358%!"

- Matt

"You have done once again!! You are reminding me of the GREAT Joe DiMaggio with your consistent hitting!! You knocked this one out of the park!"

- Keith S.

“Loving this. Should have started a long time ago.”

- Jay

Share This